+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bionic Eyes - Global Strategic Business Report

  • PDF Icon

    Report

  • 286 Pages
  • June 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6070135
Description Jump to:
The global market for Bionic Eyes was estimated at US$327.2 Million in 2024 and is projected to reach US$657.1 Million by 2030, growing at a CAGR of 12.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Bionic Eyes market.

Global Bionic Eyes Market - Key Trends & Drivers Summarized

How Are Technological Breakthroughs Redefining the Bionic Eyes Market?

The field of bionic eyes is experiencing rapid advancements driven by cutting-edge technologies in neuroprosthetics, artificial intelligence, and bioelectronics. Scientists and researchers are developing high-resolution retinal implants, optogenetics-based vision restoration, and wireless visual prosthetics, significantly enhancing the functionality of bionic eyes. The integration of AI-powered image processing allows these implants to interpret visual data more effectively, providing users with sharper, clearer, and more adaptive vision capabilities. Miniaturization of components and the use of biocompatible materials have improved implant longevity and comfort, making bionic eyes a viable long-term solution for individuals suffering from degenerative eye conditions. Moreover, developments in brain-computer interface (BCI) technology are paving the way for direct visual cortex stimulation, which has the potential to restore vision even in cases where optic nerve damage has occurred. As research progresses, the industry is witnessing a shift from traditional camera-based implants to more advanced solutions capable of real-time environmental adaptation, setting the stage for a transformative impact in vision restoration.

Why Is the Demand for Bionic Eyes Rising Across Demographics?

The increasing prevalence of visual impairments worldwide is a crucial factor driving the demand for bionic eyes. According to the World Health Organization (WHO), over 285 million people suffer from vision loss, with a significant proportion affected by age-related macular degeneration (AMD), diabetic retinopathy, and retinitis pigmentosa. The aging global population, particularly in developed nations, has fueled the need for advanced vision restoration solutions, leading to greater adoption of bionic eye implants. In parallel, rising cases of diabetes-induced vision loss and congenital eye disorders have further expanded the market scope. Another factor contributing to this demand is the growing awareness and acceptance of assistive medical technologies, supported by government initiatives and healthcare policies aimed at improving accessibility to vision restoration devices. With increased investments in ophthalmology research and higher healthcare expenditure, bionic eye solutions are gradually transitioning from experimental to commercially viable products, promising life-changing benefits for millions of visually impaired individuals worldwide.

How Are Key Industry Players and Strategic Investments Shaping the Market?

The competitive landscape of the bionic eyes market is marked by a strong emphasis on research and development (R&D), strategic partnerships, and collaborative innovations. Leading companies such as Second Sight Medical Products, Pixium Vision, and Bionic Vision Technologies are at the forefront of developing next-generation visual prosthetics. The integration of nanotechnology, wireless power transmission, and cloud-based data processing in bionic eye systems has enhanced device efficiency, opening new opportunities for market expansion. Additionally, collaboration between medical institutions, tech firms, and universities has accelerated the pace of innovation, leading to the commercialization of more sophisticated bionic eye solutions. As regulatory frameworks evolve, companies are investing heavily in clinical trials to secure approvals from regulatory bodies such as the U.S. FDA and the European Medicines Agency (EMA). With venture capital firms and government funding bolstering research initiatives, the industry is on track to deliver increasingly effective and widely accessible vision restoration solutions. Moreover, the growing influence of AI and robotics in the healthcare sector is expected to redefine patient experiences, driving broader acceptance and adoption of bionic eye technology.

What Are the Key Drivers Accelerating the Growth of the Bionic Eyes Market?

The growth in the bionic eyes market is driven by several factors, including technological advancements, increasing prevalence of vision-related disorders, and expanding applications in ophthalmology. Breakthroughs in bioengineered retinal implants, optoelectronic devices, and neural interfacing have significantly improved the efficacy of bionic eyes, making them a compelling option for vision restoration. The rising global burden of eye diseases, coupled with the aging population, has intensified demand for advanced treatment options, positioning bionic eye technology as a crucial solution for visual impairments. Additionally, the increasing affordability of implantable medical devices, aided by government subsidies and insurance coverage, has facilitated greater accessibility in both developed and emerging economies. Consumer behavior is also evolving, with growing acceptance of wearable and implantable assistive technologies reshaping market trends. Furthermore, strategic investments in AI-driven visual enhancement tools and augmented reality (AR) integration are propelling the market forward, offering new possibilities for patients with severe vision loss. As the industry moves toward more patient-centric innovations, the convergence of biotechnology, digital health, and precision medicine will continue to accelerate the adoption of bionic eyes on a global scale.

Scope of Study:

The report analyzes the Bionic Eyes market in terms of units by the following Segments, and Geographic Regions/Countries:
  • Segments: Product Type (External Eye, Implanted Eye); End-Use (Hospitals End-Use, Outpatient Facilities End-Use, Research & Manufacturing End-Use)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the External Eye segment, which is expected to reach US$422.9 Million by 2030 with a CAGR of a 11.5%. The Implanted Eye segment is also set to grow at 13.9% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $89.1 Million in 2024, and China, forecasted to grow at an impressive 16.4% CAGR to reach $136.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Bionic Eyes Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Bionic Eyes Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Bionic Eyes Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Bionic Vision Technologies, CorneaGen, Cortigent, Inc., Geuder AG, Iridium Medical Technology Co., Ltd and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 52 companies featured in this Bionic Eyes market report include:

  • Bionic Vision Technologies
  • CorneaGen
  • Cortigent, Inc.
  • Geuder AG
  • Iridium Medical Technology Co., Ltd
  • Labtician Ophthalmics, Inc.
  • LambdaVision, Inc.
  • Nanochap Electronics Co., Ltd
  • Neostrata Co., Inc.
  • Optobionics
  • Science Corporation
  • Zyvex Labs, LLC

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Bionic Eyes - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Global Incidence of Retinal Degenerative Diseases Drives Demand for Bionic Eye Solutions
Expansion of Vision Restoration Research Throws the Spotlight on Retinal Implant and Neurovisual Interfaces
OEM Focus on Artificial Photoreceptors and Retinal Microelectrode Arrays Spurs Development of Visual Prosthetics
Growth in Cortical Visual Prosthesis Programs Expands Access to Non-Retina-Dependent Bionic Eye Models
Regulatory Progress in Human Trials and Compassionate Use Exemptions Supports Market Readiness
Advancements in AI-Powered Image Processing Enhance Real-Time Visual Perception and Navigation
Partnerships Between Ophthalmology Institutions and Neurotech Firms Accelerate Clinical Validation Pipelines
Increased Use of Augmented Reality and Depth Mapping Fuels Smart Navigation Integration in Bionic Eyes
Growth in Wearable Vision Enhancement Devices Supports Gradual Transition Toward Fully Implanted Systems
OEM Innovation in Wireless Power and Minimally Invasive Implantation Techniques Enhances Surgical Adoption
Public and Private Investment in Blindness Reversal Technologies Expands Bionic Eye R&D Funding
Use of Bionic Eyes in Visual Training and Rehabilitation Centers Promotes Post-Implant Therapy Continuity
Integration With Companion Apps and Cloud-Based Vision Analytics Enhances Functional Feedback Loops
Emerging Use in Color Blindness Correction and Visual Contrast Enhancement Expands Non-Therapeutic Applications
Rising Demand for Visual Independence Among the Elderly Strengthens Business Case for Vision Restoration
Global Increase in Retinitis Pigmentosa and AMD Cases Propels Growth in Retinal Prosthesis Segment
OEM Collaboration With AI Vision Algorithms and Machine Learning Models Enables Adaptive Vision Processing
Challenges in Electrode-Tissue Biocompatibility Drive Innovation in Coatings and Materials Science
Regulatory Pathway Harmonization Across Markets Encourages Cross-Border Clinical Trials and Adoption
Long-Term Safety Data and Real-World Case Studies Strengthen Physician and Patient Confidence in Bionic Eye Devices
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Bionic Eyes Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Bionic Eyes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Bionic Eyes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Bionic Eyes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for External Eye by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for External Eye by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for External Eye by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Implanted Eye by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Implanted Eye by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Implanted Eye by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Outpatient Facilities End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Outpatient Facilities End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Outpatient Facilities End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Research & Manufacturing End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Research & Manufacturing End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Research & Manufacturing End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 20: USA Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 21: USA Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 22: USA 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
TABLE 23: USA Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 24: USA Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 25: USA 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
CANADA
TABLE 26: Canada Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 27: Canada Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 28: Canada 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
TABLE 29: Canada Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 31: Canada 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
JAPAN
Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 32: Japan Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 33: Japan Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 34: Japan 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
TABLE 35: Japan Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 37: Japan 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
CHINA
Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 38: China Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 39: China Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 40: China 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
TABLE 41: China Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 42: China Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 43: China 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
EUROPE
Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 44: Europe Recent Past, Current & Future Analysis for Bionic Eyes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 45: Europe Historic Review for Bionic Eyes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 46: Europe 15-Year Perspective for Bionic Eyes by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 47: Europe Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 49: Europe 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 52: Europe 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
FRANCE
Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 53: France Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 54: France Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 55: France 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
TABLE 56: France Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 57: France Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 58: France 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
GERMANY
Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 59: Germany Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 60: Germany Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 61: Germany 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
TABLE 62: Germany Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 64: Germany 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
ITALY
TABLE 65: Italy Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 66: Italy Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 67: Italy 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
TABLE 68: Italy Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 70: Italy 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
UNITED KINGDOM
Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 71: UK Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 72: UK Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 73: UK 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
TABLE 74: UK Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 75: UK Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 76: UK 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
SPAIN
TABLE 77: Spain Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 78: Spain Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 79: Spain 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
TABLE 80: Spain Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 81: Spain Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 82: Spain 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
RUSSIA
TABLE 83: Russia Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 84: Russia Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 85: Russia 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
TABLE 86: Russia Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 87: Russia Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 88: Russia 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 90: Rest of Europe Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 91: Rest of Europe 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 93: Rest of Europe Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 94: Rest of Europe 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Bionic Eyes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 96: Asia-Pacific Historic Review for Bionic Eyes by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 97: Asia-Pacific 15-Year Perspective for Bionic Eyes by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Bionic Eyes by Product Type - External Eye and Implanted Eye - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 99: Asia-Pacific Historic Review for Bionic Eyes by Product Type - External Eye and Implanted Eye Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 100: Asia-Pacific 15-Year Perspective for Bionic Eyes by Product Type - Percentage Breakdown of Value Sales for External Eye and Implanted Eye for the Years 2015, 2025 & 2030
TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 102: Asia-Pacific Historic Review for Bionic Eyes by End-Use - Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 103: Asia-Pacific 15-Year Perspective for Bionic Eyes by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Outpatient Facilities End-Use and Research & Manufacturing End-Use for the Years 2015, 2025 & 2030
AUSTRALIA
Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREA
REST OF ASIA-PACIFIC
LATIN AMERICA
Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINA
BRAZIL
MEXICO
REST OF LATIN AMERICA
MIDDLE EAST
Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRAN
ISRAEL
SAUDI ARABIA
UNITED ARAB EMIRATES
REST OF MIDDLE EAST
AFRICA
Bionic Eyes Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bionic Vision Technologies
  • CorneaGen
  • Cortigent, Inc.
  • Geuder AG
  • Iridium Medical Technology Co., Ltd
  • Labtician Ophthalmics, Inc.
  • LambdaVision, Inc.
  • Nanochap Electronics Co., Ltd
  • Neostrata Co., Inc.
  • Optobionics
  • Science Corporation
  • Zyvex Labs, LLC

Table Information

Report AttributeDetails
No. of Pages286
PublishedJune 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 327.2 Million
Forecasted Market Value ( USD ) by 2030 $ 657.1 Million
Compound Annual Growth Rate12.3%
Regions CoveredGlobal

Related Topics

Related Reports

Bionic Eye Market Report and Forecast 2024-2032 - Product Image

Bionic Eye Market Report and Forecast 2024-2032

  • Report
  • 200 Pages
  • Global
From
Artificial Eyes - Global Strategic Business Report - Product Image

Artificial Eyes - Global Strategic Business Report

  • Report
  • 140 Pages
  • Global
From
Artificial Eye Market 2025-2029 - Product Image

Artificial Eye Market 2025-2029

  • Report
  • 216 Pages
  • Global
From
Artificial Eye Market by Product Type, End User, Application, Material - Global Forecast to 2030 - Product Image

Artificial Eye Market by Product Type, End User, Application, Material - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Bionic Eye Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Bionic Eye Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.